Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis

Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis

Anti-cyclic citrullinated peptide (anti-CCP) was positive in 11.5 % and rheumatoid factor was positive in 8.8 % of the patients with Brucella . After a comparative evaluation, we have found out that there was not a statistical significance concerning the anti-CCP levels between the patients with bru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology international 2014-06, Vol.34 (6), p.873-874
Hauptverfasser: Kisacik, Bunyamin, Dag, Muhammet Said, Pehlivan, Yavuz, Ugurlu, Kenan, Mercan, Ozge Kaya, Aydinli, Musa, Devay, Seda Duygulu, Sayarlioglu, Mehmet, Onat, Ahmet Mesut
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Arthritis, Rheumatoid - immunology
Autoantibodies - immunology
Brucellosis - immunology
Case-Control Studies
Female
Humans
Letter to the Editor
Male
Medicine
Medicine & Public Health
Middle Aged
Peptides, Cyclic - immunology
Rheumatoid Factor - immunology
Rheumatology
Young Adult
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Anti-cyclic citrullinated peptide (anti-CCP) was positive in 11.5 % and rheumatoid factor was positive in 8.8 % of the patients with Brucella . After a comparative evaluation, we have found out that there was not a statistical significance concerning the anti-CCP levels between the patients with brucellosis and healthy control.
ISSN:0172-8172
1437-160X
DOI:10.1007/s00296-013-2777-1